Anavex Life Sciences Corp. Profile Avatar - Palmy Investing

Anavex Life Sciences Corp.

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial…

Biotechnology
US, New York [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Anavex Life Sciences Corp. has no acquisition track records yet.

M&A Deals · History

Anavex Life Sciences Corp. has no acquisition track records yet.

End of AVXL's Analysis
CIK: 1314052 CUSIP: 032797300 ISIN: US0327973006 LEI: - UEI: -
Secondary Listings
AVXL has no secondary listings inside our databases.